Brief: Cue Health Receives FDA Emergency Use Authorization For Molecular Mpox Test

Cue Health

20/03/2023 13:16

March 20 (Reuters) - Cue Health Inc  HLTH.O :
    * CUE HEALTH RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR
MOLECULAR MPOX TEST
    * CUE HEALTH : MOLECULAR MPOX TEST AUTHORIZED TO BE USED IN
PROFESSIONAL POINT-OF-CARE SETTINGS

Source text for Eikon:  ID:nBwc8y1Zja 
Further company coverage:  HLTH.O 

 ((Reuters.Briefs@thomsonreuters.com;;))